A detailed history of Ronald Blue Trust, Inc. transactions in Illumina, Inc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 528 shares of ILMN stock, worth $63,713. This represents 0.0% of its overall portfolio holdings.

Number of Shares
528
Previous 565 6.55%
Holding current value
$63,713
Previous $53,000 18.87%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 16, 2026

SELL
$91.0 - $123.54 $3,367 - $4,570
-37 Reduced 6.55%
528 $63,000
Q3 2025

Oct 16, 2025

SELL
$91.69 - $109.88 $8,160 - $9,779
-89 Reduced 13.61%
565 $53,000
Q2 2025

Jul 24, 2025

BUY
$70.3 - $95.41 $17,785 - $24,138
253 Added 63.09%
654 $62,000
Q1 2025

Apr 21, 2025

SELL
$79.34 - $144.22 $1,348 - $2,451
-17 Reduced 4.07%
401 $31,000
Q4 2024

Jan 30, 2025

SELL
$128.99 - $155.15 $79,844 - $96,037
-619 Reduced 59.69%
418 $55,000
Q4 2024

Jan 22, 2025

BUY
$128.99 - $155.15 $19,864 - $23,893
154 Added 17.44%
1,037 $138,000
Q3 2024

Oct 17, 2024

SELL
$105.28 - $135.9 $173,817 - $224,370
-1,651 Reduced 65.15%
883 $115,000
Q2 2024

Jul 18, 2024

BUY
$101.05 - $133.57 $244,945 - $323,773
2,424 Added 2203.64%
2,534 $264,000
Q1 2024

May 01, 2024

SELL
$127.73 - $147.2 $6,003 - $6,918
-47 Reduced 29.94%
110 $15,000
Q4 2023

Jan 18, 2024

SELL
$92.79 - $142.53 $3,897 - $5,986
-42 Reduced 21.11%
157 $22,000
Q3 2023

Oct 11, 2023

SELL
$128.91 - $192.44 $10,441 - $15,587
-81 Reduced 28.93%
199 $38,000
Q2 2023

Jul 14, 2023

SELL
$183.43 - $232.67 $11,922 - $15,123
-65 Reduced 18.84%
280 $65,000
Q1 2023

Apr 17, 2023

BUY
$193.75 - $232.55 $6,393 - $7,674
33 Added 10.58%
345 $70,000
Q4 2022

Jan 17, 2023

BUY
$187.24 - $242.74 $11,796 - $15,292
63 Added 25.3%
312 $59,000
Q3 2022

Oct 21, 2022

BUY
$177.23 - $227.44 $2,303 - $2,956
13 Added 5.51%
249 $46,000
Q2 2022

Aug 09, 2022

BUY
$181.58 - $368.0 $42,852 - $86,848
236 New
236 $83,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $19B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Ronald Blue Trust, Inc. Portfolio

Follow Ronald Blue Trust, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.